Publications by authors named "John Slof"

Claim this Profile
C
Costs during the first year after stroke by degree of functional disability: A societal perspective.
Mercè Soler-Font, Aida Ribera, Ignacio Aznar-Lou, Alba Sánchez-Viñas, John Slof

Eur Stroke J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care-related quality of life of informal caregivers of stroke survivors: Cross-sectional analysis of a randomized clinical trial.
Lorena Villa-García, Mercè Salvat-Plana, John Slof, Natalia Pérez de la Ossa, Sònia Abilleira

PLoS One· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement.
Aida Ribera, John Slof, Ignacio Ferreira-González, Vicente Serra, Bruno García-Del Blanco

Eur J Health Econ· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Intrathecal Baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective.
Joan Vidal, John Slof, David Serrano, Teresa Marqués, Hatice Kumru

Expert Rev Pharmacoecon Outcomes Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.
John Slof, Leonardo Ruiz, Carlos Vila

Expert Rev Pharmacoecon Outcomes Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
Aida Ribera, John Slof, Rut Andrea, Carlos Falces, Enrique Gutiérrez

Int J Cardiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sativex® in multiple sclerosis spasticity: a cost-effectiveness model.
John Slof, Adrien Gras

Expert Rev Pharmacoecon Outcomes Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
John Slof

Appl Health Econ Health Policy· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis